Integrin Targeting Therapies in Pulmonary Arterial Hypertension: A Roadmap for Traversing the Translational Valley of Death?
Circulation
.
2025 Apr 22;151(16):1184-1186.
doi: 10.1161/CIRCULATIONAHA.125.074059.
Epub 2025 Apr 21.
Authors
Vineet Agrawal
1
2
3
,
Anna R Hemnes
1
4
Affiliations
1
Pulmonary Circulation Center (V.A., A.R.H.), Vanderbilt University Medical Center, Nashville, TN.
2
Division of Cardiovascular Medicine (V.A.), Vanderbilt University Medical Center, Nashville, TN.
3
Department of Veterans Affairs, Nashville, TN (V.A.).
4
Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN (A.R.H.).
PMID:
40258053
PMCID:
PMC12014143
(available on
2026-04-22
)
DOI:
10.1161/CIRCULATIONAHA.125.074059
No abstract available
Keywords:
Editorials; familial primary pulmonary hypertension; pulmonary arterial hypertension.
Publication types
Editorial
Comment
Grants and funding
R01 FD007627/FD/FDA HHS/United States
R01 HL142720/HL/NHLBI NIH HHS/United States
R01 HL163960/HL/NHLBI NIH HHS/United States